MicroCyto
At a glance
- Status
- Operational
- Headquarters
- China
- Open positions
- None listed
- Dealroom signal
- 21.6/100
Knowledge graph
More headlines
Funding history
Company financing events and reported valuations.
| Deal type | Date | Amount | Valuation | Investors | Source |
|---|---|---|---|---|---|
| SEED✓Equity / VC | May 2022 | $15M | $60M | BioTrack Capital · Henan Investment Group Huirong Fund · Matrix Partners China · K2VC | ↗ |
Investments and acquisitions
Recent portfolio relationships for companies that also act as investors or acquirers.
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Seed5 investors entered at this stage
Matrix Partners China
BioTrack Capital- HFHenan Investment Group Huirong Fund
- K2K2VC
Hongshi Capital
Source: Dealroom Talent Intelligence.
Global footprint
Market sentiment
An AI-synthesised read of the highest-engagement posts about MicroCyto on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See MicroCyto’s full profile on Dealroom
Request a free trial to see the complete deal history, financials, people graph and growth signals.
Takes under a minute. Already use Dealroom? Log in.